JACKSONVILLE, Fla., Oct. 7, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson*, a global leader in eye health, announced new data on the ACUVUE OASYS MAX 1-Day for ASTIGMATISM ...
Johnson & Johnson announced at Optometry’s Meeting that its Acuvue Oasys 1-Day for Astigmatism contact lenses will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results